Tresuvi 5 mg/ml inf. sol. i.v. vial Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tresuvi 5 mg/ml inf. sol. i.v. vial

orpha-devel handels und vertriebs gmbh - treprostinil 5 mg - solution for infusion - 5 mg/ml - treprostinil 5 mg/ml - treprostinil

Tresuvi 10 mg/ml inf. sol. i.v. vial Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tresuvi 10 mg/ml inf. sol. i.v. vial

orpha-devel handels und vertriebs gmbh - treprostinil 10 mg - solution for infusion - 10 mg/ml - treprostinil 10 mg/ml - treprostinil

Tresuvi 2.5 mg/ml inf. sol. i.v. vial Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tresuvi 2.5 mg/ml inf. sol. i.v. vial

orpha-devel handels und vertriebs gmbh - treprostinil 2,5 mg - solution for infusion - 2,5 mg/ml - treprostinil 2.5 mg/ml - treprostinil

Treposuvi 10mg/10ml solution for infusion vials Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

treposuvi 10mg/10ml solution for infusion vials

aop orphan ltd - treprostinil sodium - solution for infusion - 1mg/1ml

Treposuvi 25mg/10ml solution for infusion vials Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

treposuvi 25mg/10ml solution for infusion vials

aop orphan ltd - treprostinil sodium - solution for infusion - 2.5mg/1ml

Treposuvi 50mg/10ml solution for infusion vials Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

treposuvi 50mg/10ml solution for infusion vials

aop orphan ltd - treprostinil sodium - solution for infusion - 5mg/1ml

Treposuvi 100mg/10ml solution for infusion vials Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

treposuvi 100mg/10ml solution for infusion vials

aop orphan ltd - treprostinil sodium - solution for infusion - 10mg/1ml

Oncaspar Evropská unie - angličtina - EMA (European Medicines Agency)

oncaspar

les laboratoires servier - pegaspargase - precursor cell lymphoblastic leukemia-lymphoma - antineoplastic agents, - oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (all) in paediatric patients from birth to 18 years, and adult patients.,

Travoprost - 1 A Pharma 40 Mikrogramm/ml Augentropfen, Lösung Německo - angličtina - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

travoprost - 1 a pharma 40 mikrogramm/ml augentropfen, lösung

Travoprost HEXAL 40 Mikrogramm/ml Augentropfen, Lösung Německo - angličtina - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

travoprost hexal 40 mikrogramm/ml augentropfen, lösung